April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
The neuroprotection of Angiotensin-(1-7) in Tg(RHO P347S) and rd10 mice
Author Affiliations & Notes
  • Ping Zhu
    Ophthalmology, University of Florida, Gainesville, FL
  • Pollob Kumar Shil
    Ophthalmology, University of Florida, Gainesville, FL
  • Wen-tao Deng
    Ophthalmology, University of Florida, Gainesville, FL
  • Jie Li
    Ophthalmology, University of Florida, Gainesville, FL
  • Amrisha Verma
    Ophthalmology, University of Florida, Gainesville, FL
  • Tuhina Prasad
    Ophthalmology, University of Florida, Gainesville, FL
  • Qiuhong Li
    Ophthalmology, University of Florida, Gainesville, FL
  • Footnotes
    Commercial Relationships Ping Zhu, None; Pollob Shil, None; Wen-tao Deng, None; Jie Li, None; Amrisha Verma, None; Tuhina Prasad, None; Qiuhong Li, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 6187. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ping Zhu, Pollob Kumar Shil, Wen-tao Deng, Jie Li, Amrisha Verma, Tuhina Prasad, Qiuhong Li; The neuroprotection of Angiotensin-(1-7) in Tg(RHO P347S) and rd10 mice. Invest. Ophthalmol. Vis. Sci. 2014;55(13):6187. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Ang-(1-7) is an endogenous peptide that counter-regulates the effect of Angiotensin II and produces vasodilation, anti-inflammation and cardioprotection. In addition, Ang-(1-7) also confers cerebroprotection against ischemia and improves learning and memory. These effects are mediated by Mas receptor. We recently show that Mas receptor is expressed in both adult and developing mouse retina, more abundant in retinal neurons than endothelial and muller glial cells. We hypothesize that increased Ang-(1-7) would confer retinal neuroprotection and slow photoreceptor degeneration. We tested this hypothesis in two different animal models of photoreceptor degeneration: Tg(RHO P347S) and rd10 mice, by intraocular delivery of AAV vector expressing Ang-(1-7).

Methods: The Tg(RHO P347S) pups were injected with 1 μl (1× 1012 vg/ml) of AAV2 vector expressing secreted form of Ang-(1-7) intravitreally in right eyes on postnatal day 10-15 (P10-15) and rd10 pups on P9. The left contralateral eyes served as untreated controls. Full-field rod- and cone-mediated ERG were recorded at P60 for Tg(RHO P347S) and 6 wk for rd10 mice. A series of increasing flash intensities (−3.7,-1.7,−0.7, 0.3, 2.3, and 2.8 log cds/m2) were recorded after overnight dark adaptation. Photopic recordings were taken after mice were adapted to a white background light of 2.8 log cd/m2 for 5 min. Rod and cone photoreceptor degeneration was evaluated by immunofluorescence staining, in situ apoptosis detection and histology.

Results: There was no significant difference between treated and untreated eyes in rod-driven scotopic ERG responses in both models. However cone-driven photopic ERG was significantly improved in Ang-(1-7)-AAV treated eyes. The average cone b-wave amplitude of Tg(RHO P347S) mice was 140.38 ± 32.76 μV in injected eyes versus 119.65 ± 24.78 μV in untreated eyes at 2.8 log cds/m2(n=6). The average cone b-wave amplitude of rd10 was 206.37 ± 24.87 μV in injected eyes versus 173.67 ± 24.42 μV in untreated eyes at 2.8 log cds/m2 (n=3). Ang-(1-7)-AAV vector treated eyes also show significantly reduced cone photoreceptor loss detected by cone opsin staining compared to untreated eyes.

Conclusions: Increased ocular expression of Ang-(1-7) slowed the progression cone photoreceptor degeneration in both Tg(RHO P347S) and rd10 mice, supporting the protective role of Ang-(1-7) in the retina and this approach may provide a general strategy for neuroprotection.

Keywords: 538 gene transfer/gene therapy • 696 retinal degenerations: hereditary  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×